Dr. Wasim Samara, MD

Dr. Samara practices at North Carolina Retina Associates in Raleigh, North Carolina.

Dr. Samara's NPI, 1275995177, was assigned on March 22, 2016. Dr. Samara graduated from University of Jordan Faculty of Medicine in 2013. Dr. Samara's Alabama license number on file is MD.39373.

Dr. Samara's primary practice is North Carolina Retina Associates, at 4414 Lake Boone Trl, Raleigh, NC 27607 in Wake County. The practice phone is (919) 782-8038.

Dr. Samara's primary practice is North Carolina Retina Associates in Raleigh, North Carolina. The medical group on file is ECU Health. Dmand AI also links Dr. Samara to 2 more medical groups, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Samara practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Samara's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Samara is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Samara's licenses on file in 5 states: Alabama, Tennessee, North Carolina, Texas and Virginia.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, glaucoma, hereditary corneal conditions, hypertensive retinopathy, inflammation of iris and laser destruction of retinal or choroid lesions among the conditions Dr. Samara treats.

CMS data shows 15,270 Medicare services from Dr. Samara across 15 procedure codes in 2024, for 807 Medicare patients. Medicare paid $2,117,036 for them. Every service was in an office.

CMS counts 807 Medicare patients who saw Dr. Samara in 2024. The largest group is 75 to 84, with 312 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Samara's median patient age at 72, with 55% women.

In 2024, Dr. Samara wrote 459 Medicare Part D claims for 138 patients. 61% of them were for generic drugs. CMS names the drug for 430 of them, across 9 drugs with 11 or more claims each, at $11,997 in total drug cost. In 2023, CMS named 421 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Samara for performance year 2024, reported as part of a group. Dr. Samara accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 33 papers to Dr. Samara, published from 2015 to 2023. 2016 was the busiest year, with 8. The most frequent topics are Tomography, Optical Coherence, Fluorescein Angiography and Visual Acuity. Dr. Samara has published most often in Retina. Dr. Samara's most frequent co-authors are Abtin Shahlaee, MD, Jayanth Srinivasan-Kasi Sridhar, MD and Allen C. Ho, MD.

CMS Open Payments shows 91 general payments to Dr. Samara from 15 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $966.

Dr. Samara graduated from University of Jordan Faculty of Medicine in 2013.

Dr. Samara is in network with 18 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.